Scientists have discovered that mutations in the EPG5 gene—known for causing the rare childhood disorder Vici syndrome—also increase the risk of Parkinson’s disease and dementia later in life.

All eyes are on the chip maker as it prepares a full-court press into a new process technology, spearheaded by chips for ...

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...

General Motors Company ( NYSE: GM) Q3 2025 Earnings Call October 21, 2025 8:30 AM EDT Good morning, and welcome to the General Motors Company Third Quarter 2025 Earnings Conference Call. [Operator ...

Go big or go home? The Samsung Galaxy Tab S11 Ultra is still the oversized Android slate to beat, even if annual upgrades ...

Investors were treated to presentations from ASX companies across a range of industries amid the iconic backdrop of the ...

Why on earth would anyone spend €13,000 to buy a 3-meter BEV that seats only four people and can drive only 120 km (75 miles) ...

In hindsight, the telltale signs of trouble were piling up: the Zoom calls where the owner kept his camera off; the angry pushback from his brother when investors asked for invoices to back up their ...

Q3 2025 Earnings Call Transcript October 14, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced positive topline ...

The writer-director turned to everything from all-time classics like "Singin' in the Rain" to obscure titles like "Nancy Goes ...

CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...